medindia
  1. Medindia
  2. Health Tips and Quotations

FDA Approved Combination Treatment for Acute Myeloid Leukemia (AML)

The United States Food and Drug Administration has recently approved the use of Midostaurin (Rydapt) drug along with chemotherapy for treating patients with acute myeloid leukemia (AML), with a specific gene mutation called FLT3 (FMS-like tyrosine kinase 3).

FDA approves combination treatment for acute myeloid leukemia (AML) - Acute myeloid leukemia (AML) is a tyoe of cancer in the bone marrow - Midostaurin drug is used along with chemotherapy for treating AML

Midostaurin and Chemotherapy Combination Approved by FDA for Acute Myeloid Leukemia Treatment

The United States Food and Drug Administration has approved the use of midostaurin drug along with chemotherapy for acute myeloid leukemia treatment. Read More

Related Links

How to Keep Your Bones Strong and Healthy as You Age
Beat Summer Fatigue: Tips to Stay Energized and Cool
Anti-Ageing Mantra: Can Eating Less Slow Down Aging?
What Happens When You Wake Up Early?
Breathe Easy: Why Sleeping With Your Mouth Closed Matters
Are Bread and Butter Really Unhealthy? ICMR Advise on Ultra-Processed Foods
Reheat Alert: ICMR on Reusing Cooking Oil
Is Salt Sabotaging Your Health? 10 Warning Signs You Can't Ignore
Is Your Coconut Water Contaminated? Shocking Truth About Mold Growth
Alcohol? More Like Alco-NO! This Gel can Say Goodbye to Hangovers
The Colourful Controversy of Food Dyes
The Impact of Vitamin Deficiencies on Fertility: Insights for Men and Women

Wildcard SSL

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment.
Full Disclaimer

Advertise with us | Medindia Copyright | Privacy Policy | Terms of Use © All Rights Reserved 1997 - 2024